Dépistage primaire des complications du diabète – Revue systématique
Statut du projet: Terminé
Utilisateur(s) des connaissances
Action diabète Canada
Source(s) de financement
Instituts de recherche en santé du Canada (IRSC), dans le cadre de l’Alliance pour des données probantes de la Stratégie de recherche axée sur le patient (SRAP), Action diabète Canada
Objectif du projet
1) Effectuer une revue systématique de l’efficacité et la rentabilité des modèles de dépistage primaire de la rétinopathie diabétique, de la néphropathie et des ulcères du pied auprès de la population; 2) consigner les études publiées sur le dépistage parmi les Autochtones.
Approche de recherche
Examen de la portée
Responsables du projet
Fiona Clement
Fiona Clement has extensive training in Health Services Research, Health Economics and Health Policy. She is the Director of the Health Technology Assessment Unit within the O’Brien Institute of Public Health, University of Calgary; a policy responsive research unit that completes evidence synthesis, economic evaluations, health technology assessments and reassessments in response to decision-makers’ needs. Her research interests include drug and non-drug technology reimbursement and cost containment policy, evidence in decision-making, and evidence in health policy development.
Dr. Clement was selected as the Canadian Harkness fellow in 2014; a unique opportunity to study US healthcare policy. She has also received the Maurice McGregor Award for outstanding leadership and excellence in HTA in Canada. She is the first from Alberta to be awarded either of these awards. As a result, in 2015, she was named one of Calgary’s Top 40 under 40 for her work in health policy.
Fiona Clement
University of Calgary
Fiona Clement has extensive training in Health Services Research, Health…